Orthopedic Clinic EBITDA Valuation Multiples: What Buyers Are Paying in 2024
Independent orthopedic practices are trading at 4x–7x EBITDA. Here's what drives value up — and what kills it — in today's healthcare M&A market.
Orthopedic clinics are among the most actively acquired physician specialty practices in U.S. lower middle market M&A. Private equity-backed physician management groups, multi-specialty operators, and SBA-financed individual physicians are driving strong demand for independent practices generating $1M–$5M in revenue. Valuations are primarily EBITDA-driven, with multiples ranging from 4x to 7x depending on physician depth, payer mix, ancillary revenue, and compliance posture. Practices with diversified surgeon bases, in-house imaging or physical therapy, and clean Stark Law compliance command the highest multiples.
Orthopedic Clinic EBITDA Multiple Ranges by Tier
| Business Tier | EBITDA Range | Multiple Range | Notes |
|---|---|---|---|
| Tier 4 — Single-Physician, Medicare-Heavy | $300K–$600K | 4.0x–4.5x | High key-man risk, reimbursement compression, limited ancillary revenue, and thin margins reduce buyer appetite and financing options. |
| Tier 3 — Small Group, Mixed Payer Mix | $600K–$1.2M | 4.5x–5.5x | 2–3 physicians, moderate commercial insurance exposure, some ancillary services; SBA-eligible but earnouts likely tied to physician retention. |
| Tier 2 — Established Multi-Physician Practice | $1.2M–$2.5M | 5.5x–6.5x | Strong commercial payer mix, in-house PT or imaging, documented referral base; attractive to PE platforms and MSO structures. |
| Tier 1 — Platform-Ready Orthopedic Group | $2.5M+ | 6.5x–7.0x | 4+ surgeons, diversified ancillary revenue including ASC ownership, clean compliance history, transferable payer contracts; premium PE target. |
What Drives Orthopedic Clinic Multiples
Physician Depth & Key-Man Risk
High impactPractices with 3+ surgeons command significantly higher multiples. Single-physician clinics face steep discounts due to revenue concentration and post-close retention risk.
Payer Mix — Commercial vs. Government
High impactA payer mix with 40%+ commercial insurance drives stronger margins and higher multiples. Heavy Medicare or Medicaid reliance compresses EBITDA and buyer confidence.
In-House Ancillary Revenue
Medium-High impactPhysical therapy, diagnostic imaging, DME, and ASC ownership stakes add diversified, high-margin revenue streams that meaningfully increase practice enterprise value.
Compliance & Clean Billing History
Medium-High impactDocumented adherence to Stark Law, HIPAA, and anti-kickback statutes is non-negotiable. Compliance gaps create deal-killing liability and reduce multiple by 0.5x–1.5x.
Transferable Payer Contracts & Referral Networks
Medium impactPayer contracts that transfer cleanly and documented referral volume from PCPs, ERs, or employers reduce buyer risk and support premium valuations at close.
Recent Market Trends
Private equity consolidation of orthopedic practices has accelerated since 2020, with platform groups actively acquiring practices in the $1.5M–$3M EBITDA range. MSO structures are increasingly common to navigate corporate practice of medicine restrictions. Outpatient ASC migration is boosting EBITDA margins for practices that have exited hospital-based procedures. Meanwhile, CMS reimbursement pressure on joint replacement CPT codes has modestly compressed margins for Medicare-heavy practices, widening the valuation gap between commercial and government payer-dependent clinics.
Sample Orthopedic Clinic Transactions
3-physician sports medicine and joint replacement clinic in a Southeast suburban market with in-house PT and clean compliance history
$1.4M
EBITDA
5.8x
Multiple
$8.1M
Price
5-surgeon orthopedic group with on-site MRI, physical therapy, and minority ASC ownership stake in a Midwest metro; strong commercial payer mix
$2.8M
EBITDA
6.7x
Multiple
$18.8M
Price
2-physician orthopedic practice with moderate Medicare exposure and no ancillary services; acquired via SBA 7(a) with seller note
$650K
EBITDA
4.6x
Multiple
$3.0M
Price
EBITDA Valuation Estimator
Get your Orthopedic Clinic business value range instantly
Industry: Orthopedic Clinic · Multiples based on 4.5x–5.5x (Tier 3 — Small Group, Mixed Payer Mix)
Powered by Deal Flow OS
dealflow-os.com · Free M&A tools for every stage of the deal
Frequently Asked Questions
What EBITDA multiple should I expect when selling my orthopedic clinic?
Most orthopedic clinics sell at 4x–7x EBITDA. Multi-physician practices with commercial payer mix and ancillary services typically achieve 5.5x–7x, while single-physician or Medicare-heavy practices land at 4x–4.5x.
Do orthopedic clinics qualify for SBA financing?
Yes. Orthopedic clinics are SBA 7(a) eligible, making them accessible to individual physician buyers. Lenders typically require minimum $500K EBITDA, clean compliance history, and physician employment agreements post-close.
How does physician key-man risk affect my practice valuation?
Practices dependent on one surgeon often face 0.5x–1.5x multiple discounts. Buyers price in retention risk. Adding a second physician or grooming a successor before sale materially improves your valuation outcome.
What deal structure is most common in orthopedic clinic acquisitions?
Asset purchases with physician employment and non-compete agreements are most common. PE buyers often use MSO structures for regulatory compliance, while SBA deals typically include a 10–15% seller note.
More Orthopedic Clinic Guides
Find Orthopedic Clinic businesses at the right price
DealFlow OS surfaces acquisition targets with seller signals and outreach angles. Free to join.
Start finding deals — freeNo credit card required